placeholder newsslider

News

VRmagic Eyesi Slit Lamp Fundoscopy Module Launched in the UK

VRmagic’s new Fundoscopy Module can be mounted to the Eyesi Slit Lamp simulator table to enable a lifelike interaction. It is supported by comprehensive software offering a wide selection of cases for retinal examination, which will be continuously extended, according to a company news release.

How Europe's €100 billion science fund will shape 7 years of research

Horizon Europe, the world’s largest multinational research and innovation programme, has issued its first call for grant applications.

Prof Andrew Dick reappointed as Director of IoO

Congratulations to Professor Andrew Dick for being reappointed as Director of UCL Institute of Ophthalmology for the next five years.

Aerie Pharmaceuticals Receives European Commission Approval for Glaucoma Treatment Roclanda

Aerie Pharmaceuticals announced the European Commission (EC) has granted a marketing authorization for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction of elevated IOP in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.

Beacon Bursaries awarded to IoO and Slade School of Fine Art joint project

IoO's Dr Emily Patterson and UCL Slade School of Fine Art's Jo Guile were selected in the latest round of the Beacon Bursary public engagement funding scheme.

International Council of Ophthalmology supports WHO’s guide on DR screening

The International Council of Ophthalmology participated in the launch of a diabetic retinopathy screening guide developed by the WHO Regional Office for Europe.

Tamara Fountain begins Term as 2021 President of the American Academy of Ophthalmology

The university professor will focus on pandemic recovery, supporting diversity in medicine

Fighting Blindness in the Developing World

From humble beginnings as a small clinic with just 11 beds and the audacious goal of curing preventable blindness, the Aravind Eye Care System in southern India has grown into the largest eye care provider in the world and serves as a model for how cataract blindness might effectively be eliminated in the developing world.

Le Professeur José-Alain Sahel au Téléthon 2020

José-Alain Sahel est intervenu lors du Téléthon 2020 pour évoquer les travaux de l’Institut sur les maladies rares de la Vision.

Drive-through IOP screening clinic feasible during COVID-19

A drive-through intraocular pressure (IOP) screening clinic allows for continued management during the COVID-19 pandemic, according to a research letter published in JAMA Ophthalmology.

Core curriculum: learning to manage a shared microscopy facility

High-tech tools are increasingly being consolidated into specialized centres. Running these technological wonderlands takes a unique blend of skills.

Global public health services fail to meet targets to reduce avoidable sight loss

A new global study has found no significant reduction in the number of people with treatable sight loss since 2010. Published in The Lancet Global Health, it examined population-based surveys of eye disease worldwide from 1980 and found public health services across the world are failing to meet targets to reduce avoidable sight loss.

The best science images of 2020

2020 has been a year like no other. The COVID-19 pandemic pushed science to the forefront and dominated lives. But the year also produced fresh images unrelated to the virus.

RetinAI collaborates with Novartis to provide AI solutions for ophthalmology projects

RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health. Both companies have previously worked successfully on pilot projects in this disease area.

Glaucoma Research Foundation going global

In light of the ongoing COVID-19 pandemic, the Glaucoma Research Foundation will host a virtual Glaucoma 360 annual meeting in 2021.